Breaking News

Avion Pharma Appoints President

By Kristin Brooks | March 12, 2014

Sullivan to lead growth initiatives

Mike Sullivan has been named president of Avion Pharmaceuticals. Mr. Sullivan joined the company in 2011 as vice president of sales and marketing. He has expertise in building corporate "start-up" pharmaceutical organizations and has been instrumental in the commercial development, infrastructure and successful launch of Avion during the past three years. Mr. Sullivan has spearheaded eight product launches at Avion, while also re-launching the prescription Prenate Prenatal Vitamin Family. Mr. Sullivan has also held senior management positions with UCB Pharma, Novartis, Sanofi and Ther-Rx Pharmaceuticals.     

"I am pleased to announce Mike's promotion and applaud his inexhaustible dedication to drive continuous success for Avion Pharmaceuticals. Mike exhibits endless passion in realizing our strategic mission to be the leading pharmaceutical company in the U.S. devoted to women's healthcare. With Mike's leadership, Avion is positioned to continue our growth through innovation by providing women and babies with products and support needed to live healthy and rewarding lives," said Mark Pugh, chief executive officer for Avion Pharmaceuticals.

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks